{
  "ptid_time": "024_S_4905_2013-08-26",
  "img_path": "/data/qiuhui/data/adni/images/024_S_4905/2013-08-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,828 mm³, 31.2% above the reference mean. With a Z-score of 0.71 (76.3th percentile), this represents normal volume ; hippocampal volume measures 5,414 mm³, 23.9% below the reference mean. With a Z-score of -2.19 (1.4th percentile), this represents significant atrophy; whole brain volume measures 957,513 mm³, 1.8% below the reference mean. With a Z-score of -0.22 (41.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,567 mm³, 30.1% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,934 mm³, 12.2% below the reference mean. With a Z-score of -1.11 (13.3th percentile), this represents mild atrophy; middle temporal gyrus volume measures 14,516 mm³, 24.3% below the reference mean. With a Z-score of -2.11 (1.8th percentile), this represents significant atrophy. ",
  "text_data": "Age is 73.7 years. Gender is Female. Education: 12 years. MMSE: 25.0. MoCA: 21.0. Logical Memory: 7.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the hippocampus and middle temporal gyrus, along with moderate atrophy in the entorhinal cortex—key regions affected in Alzheimer's disease. Cognitive testing (MMSE 25, MoCA 21) indicates mild impairment, consistent with early-stage cognitive decline. The presence of one APOE4 allele further supports increased Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer's disease)  \n**Confidence:** **High** (due to clear structural atrophy in AD-vulnerable regions and corroborating cognitive deficits).",
  "timestamp": "2025-07-26T03:22:57.989965"
}